Cargando…

Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study

Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Zeng, Jie, Zhao, Nan, Chen, Silu, Chen, Zhong, Liao, Jingrong, Ran, Haosong, Yu, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389564/
https://www.ncbi.nlm.nih.gov/pubmed/37288546
http://dx.doi.org/10.1097/JS9.0000000000000340
_version_ 1785082328954961920
author Wang, Jing
Zeng, Jie
Zhao, Nan
Chen, Silu
Chen, Zhong
Liao, Jingrong
Ran, Haosong
Yu, Cong
author_facet Wang, Jing
Zeng, Jie
Zhao, Nan
Chen, Silu
Chen, Zhong
Liao, Jingrong
Ran, Haosong
Yu, Cong
author_sort Wang, Jing
collection PubMed
description Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing staff. Currently, there is little conclusive evidence for noninvasive moderate sedation strategies in pediatric dental surgery. MATERIALS AND METHODS: The trial was conducted from May 2022 to September 2022. Each child was first given midazolam oral solution 0.5 mg·kg(−1), and when the Modified Observer’s Assessment of Alertness and Sedation score reached 4, a biased coin design up-down method was used to adjust the dose of esketamine. The primary outcome was the ED(95) and 95% CI of intranasal esketamine hydrochloride with midazolam 0.5 mg·kg(−1). Secondary outcomes included the onset time of sedation, treatment and awakening times, and the incidence of adverse events. RESULTS: A total of 60 children were enrolled; 53 children were successfully sedated but 7 were not. The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the treatment of dental caries was 1.99 mg·kg(−1) (95% CI 1.95–2.01 mg·kg(−1)). The mean onset time of sedation for all patients was 43.7±6.9 min. 15.0 (10–24.0) min for examination and 89.4±19.5 min for awakening. The incidence of intraoperative nausea and vomiting was 8.3%. Adverse reactions such as transient hypertension and tachycardia occurred during the operations. CONCLUSION: The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the outpatient pediatric dentistry procedure under moderate sedation was 1.99 mg·kg(−1). For children aged 2–6 years with dental anxiety who require dental surgery, anesthesiologists may consider using midazolam oral solution combined with esketamine nasal drops for noninvasive sedation after a preoperative anxiety scale evaluation.
format Online
Article
Text
id pubmed-10389564
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103895642023-08-01 Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study Wang, Jing Zeng, Jie Zhao, Nan Chen, Silu Chen, Zhong Liao, Jingrong Ran, Haosong Yu, Cong Int J Surg Original Research Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing staff. Currently, there is little conclusive evidence for noninvasive moderate sedation strategies in pediatric dental surgery. MATERIALS AND METHODS: The trial was conducted from May 2022 to September 2022. Each child was first given midazolam oral solution 0.5 mg·kg(−1), and when the Modified Observer’s Assessment of Alertness and Sedation score reached 4, a biased coin design up-down method was used to adjust the dose of esketamine. The primary outcome was the ED(95) and 95% CI of intranasal esketamine hydrochloride with midazolam 0.5 mg·kg(−1). Secondary outcomes included the onset time of sedation, treatment and awakening times, and the incidence of adverse events. RESULTS: A total of 60 children were enrolled; 53 children were successfully sedated but 7 were not. The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the treatment of dental caries was 1.99 mg·kg(−1) (95% CI 1.95–2.01 mg·kg(−1)). The mean onset time of sedation for all patients was 43.7±6.9 min. 15.0 (10–24.0) min for examination and 89.4±19.5 min for awakening. The incidence of intraoperative nausea and vomiting was 8.3%. Adverse reactions such as transient hypertension and tachycardia occurred during the operations. CONCLUSION: The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the outpatient pediatric dentistry procedure under moderate sedation was 1.99 mg·kg(−1). For children aged 2–6 years with dental anxiety who require dental surgery, anesthesiologists may consider using midazolam oral solution combined with esketamine nasal drops for noninvasive sedation after a preoperative anxiety scale evaluation. Lippincott Williams & Wilkins 2023-06-05 /pmc/articles/PMC10389564/ /pubmed/37288546 http://dx.doi.org/10.1097/JS9.0000000000000340 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/ (https://creativecommons.org/licenses/by-sa/4.0/)
spellingShingle Original Research
Wang, Jing
Zeng, Jie
Zhao, Nan
Chen, Silu
Chen, Zhong
Liao, Jingrong
Ran, Haosong
Yu, Cong
Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title_full Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title_fullStr Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title_full_unstemmed Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title_short Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
title_sort intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389564/
https://www.ncbi.nlm.nih.gov/pubmed/37288546
http://dx.doi.org/10.1097/JS9.0000000000000340
work_keys_str_mv AT wangjing intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT zengjie intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT zhaonan intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT chensilu intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT chenzhong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT liaojingrong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT ranhaosong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy
AT yucong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy